X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs NOVARTIS - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. NOVARTIS WOCKHARDT LTD./
NOVARTIS
 
P/E (TTM) x -15.2 361.3 - View Chart
P/BV x 2.5 17.8 14.0% View Chart
Dividend Yield % 1.3 1.6 81.4%  

Financials

 WOCKHARDT LTD.   NOVARTIS
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
NOVARTIS
Mar-16
WOCKHARDT LTD./
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs1,129982 115.0%   
Low Rs627556 112.7%   
Sales per share (Unadj.) Rs363.1252.9 143.6%  
Earnings per share (Unadj.) Rs-20.462.1 -32.9%  
Cash flow per share (Unadj.) Rs-7.063.3 -11.0%  
Dividends per share (Unadj.) Rs10.0010.00 100.0%  
Dividend yield (eoy) %1.11.3 87.6%  
Book value per share (Unadj.) Rs301.8363.6 83.0%  
Shares outstanding (eoy) m110.5531.96 345.9%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.43.0 79.5%   
Avg P/E ratio x-42.912.4 -347.0%  
P/CF ratio (eoy) x-125.912.2 -1,035.9%  
Price / Book Value ratio x2.92.1 137.5%  
Dividend payout %-48.916.1 -303.9%   
Avg Mkt Cap Rs m97,06324,580 394.9%   
No. of employees `0006.80.8 900.0%   
Total wages/salary Rs m9,6651,801 536.6%   
Avg. sales/employee Rs Th5,931.810,748.9 55.2%   
Avg. wages/employee Rs Th1,428.12,395.2 59.6%   
Avg. net profit/employee Rs Th-334.02,641.1 -12.6%   
INCOME DATA
Net Sales Rs m40,1468,083 496.7%  
Other income Rs m1,143829 137.8%   
Total revenues Rs m41,2898,913 463.3%   
Gross profit Rs m128234 54.7%  
Depreciation Rs m1,48937 4,058.0%   
Interest Rs m2,2532 125,150.0%   
Profit before tax Rs m-2,4721,025 -241.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m017 0.0%   
Extraordinary Inc (Exp) Rs m01,696 0.0%   
Tax Rs m-211752 -28.1%   
Profit after tax Rs m-2,2601,986 -113.8%  
Gross profit margin %0.32.9 11.0%  
Effective tax rate %8.573.4 11.6%   
Net profit margin %-5.624.6 -22.9%  
BALANCE SHEET DATA
Current assets Rs m46,16012,678 364.1%   
Current liabilities Rs m19,2582,433 791.5%   
Net working cap to sales %67.0126.7 52.9%  
Current ratio x2.45.2 46.0%  
Inventory Days Days10133 308.1%  
Debtors Days Days9422 418.2%  
Net fixed assets Rs m40,16569 58,041.9%   
Share capital Rs m553160 345.9%   
"Free" reserves Rs m32,81411,460 286.3%   
Net worth Rs m33,36711,621 287.1%   
Long term debt Rs m31,9030-   
Total assets Rs m89,68714,400 622.8%  
Interest coverage x-0.1570.5 -0.0%   
Debt to equity ratio x1.00-  
Sales to assets ratio x0.40.6 79.7%   
Return on assets %013.8 -0.1%  
Return on equity %-6.817.1 -39.6%  
Return on capital %-0.323.6 -1.4%  
Exports to sales %00.7 0.0%   
Imports to sales %018.6 0.0%   
Exports (fob) Rs mNA60 0.0%   
Imports (cif) Rs mNA1,503 0.0%   
Fx inflow Rs m9,121186 4,895.8%   
Fx outflow Rs m2,1331,821 117.2%   
Net fx Rs m6,988-1,635 -427.5%   
CASH FLOW
From Operations Rs m-2,6952,531 -106.5%  
From Investments Rs m-6,863-8,270 83.0%  
From Financial Activity Rs m12,545-386 -3,252.5%  
Net Cashflow Rs m3,010-6,125 -49.2%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 2.3 2.0 115.0%  
FIIs % 7.7 1.6 481.3%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 21.5 71.6%  
Shareholders   67,757 41,647 162.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   ALEMBIC LTD  SUN PHARMA  IPCA LABS  FDC LTD.  AUROBINDO PHARMA  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Mr Modi Providing Impetus to Defense Industry and Key Stocks in Action Today(Pre-Open)

Addressing the Uttar Pradesh Investors Summit, Mr. Modi announced the creation of a defense industrial corridor in Bundelkhand.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Feb 21, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 5-YR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS